Linking Stages of Cardiovascular-Kidney-Metabolic Syndrome to All-Cause Mortality Risk in U.S. Adults: Findings from a NHANES Cross-Sectional Analysis - Report - MDSpire
Advertisement
Linking Stages of Cardiovascular-Kidney-Metabolic Syndrome to All-Cause Mortality Risk in U.S. Adults: Findings from a NHANES Cross-Sectional Analysis
Linking Stages of Cardiovascular-Kidney-Metabolic Syndrome to All-Cause Mortality Risk
Overview
This study investigates the relationship between stages of Cardiovascular-Kidney-Metabolic (CKM) syndrome and all-cause mortality risk in U.S. adults. Findings indicate that higher CKM stages correlate with increased mortality risk, emphasizing the need for early intervention and management.
Background
The American Heart Association has defined CKM syndrome as a systemic disorder that integrates obesity, chronic kidney disease, diabetes, and cardiovascular conditions. Understanding CKM syndrome is crucial due to its rising prevalence and significant impact on healthcare costs and patient outcomes. This study aims to clarify the relationship between CKM stages and mortality, addressing a critical gap in current research.
Data Highlights
Remove placeholder text and replace with relevant data or a statement about data availability.
Key Findings
CKM syndrome is classified into five stages, reflecting the severity of the disease.
Approximately 90.8% of U.S. adults were affected by CKM between 2011 and 2022.
15% of U.S. adults are classified as having advanced CKD (stage 3 or 4).
Higher CKM stages are associated with reduced life expectancy.
CKM-related medical expenditures account for over 75% of total healthcare costs in the U.S.
Clinical Implications
Healthcare professionals should be aware of the significant mortality risk associated with advanced CKM stages. Early identification and management of CKM syndrome can potentially improve patient outcomes and reduce healthcare costs.
Conclusion
The study underscores the importance of recognizing CKM syndrome stages in clinical practice to mitigate mortality risk. Further research is needed to explore effective interventions for patients at higher CKM stages.
